| 2024-05-29 | Sale | Haemonetics Corporation HAE | EVP and General Counsel | 12,990 0.0257% | $88.08 | $1.14M | -2.21% | |
| 2024-05-20 | Sale | Haemonetics Corporation HAE | EVP and General Counsel | 1,604 0.0032% | $95.08 | $152,508 | -9.99% | |
| 2024-05-17 | Sale | Haemonetics Corporation HAE | EVP and General Counsel | 1,073 0.0021% | $95.00 | $101,935 | -10.34% | |
| 2024-05-16 | Sale | Haemonetics Corporation HAE | EVP and General Counsel | 985 0.002% | $96.14 | $94,698 | -9.46% | |
| 2022-10-24 | Sale | Haemonetics Corporation HAE | EVP and General Counsel | 180 0.0004% | $80.39 | $14,470 | +4.93% | |
| 2022-09-19 | Sale | Haemonetics Corporation HAE | EVP and General Counsel | 11,448 0.0225% | $78.36 | $897,065 | +6.67% | |
| 2022-09-15 | Sale | Haemonetics Corporation HAE | EVP and General Counsel | 33,798 0.0665% | $77.89 | $2.63M | +7.46% | |
| 2022-06-13 | Sale | Haemonetics Corporation HAE | EVP and General Counsel | 277 0.0005% | $62.60 | $17,340 | +24.81% | |
| 2022-05-19 | Sale | Haemonetics Corporation HAE | EVP and General Counsel | 3,258 0.0062% | $59.10 | $192,548 | +29.7% | |
| 2022-05-16 | Sale | Haemonetics Corporation HAE | EVP and General Counsel | 196 0.0004% | $56.10 | $10,996 | +35.28% | |
| 2021-10-25 | Sale | Haemonetics Corporation HAE | EVP and General Counsel | 120 0.0002% | $71.93 | $8,632 | -16.01% | |
| 2021-06-14 | Sale | Haemonetics Corporation HAE | EVP and General Counsel | 195 0.0004% | $59.87 | $11,675 | -0.92% | |
| 2021-06-07 | Sale | Haemonetics Corporation HAE | EVP and General Counsel | 442 0.0008% | $55.09 | $24,350 | +4.66% | |
| 2021-05-19 | Sale | Haemonetics Corporation HAE | EVP and General Counsel | 220 0.0004% | $55.19 | $12,142 | +3.26% | |
| 2021-05-17 | Sale | Haemonetics Corporation HAE | EVP and General Counsel | 204 0.0004% | $55.97 | $11,418 | +2.09% | |
| 2021-03-08 | Sale | Haemonetics Corporation HAE | EVP and General Counsel | 385 0.0008% | $120.07 | $46,227 | -49.52% | |
| 2020-10-23 | Sale | Haemonetics Corporation HAE | EVP and General Counsel | 181 0.0004% | $106.58 | $19,291 | -34% | |
| 2020-06-16 | Sale | Haemonetics Corporation HAE | EVP and General Counsel | 13,436 0.0268% | $91.02 | $1.22M | +5.01% | |
| 2020-06-15 | Sale | Haemonetics Corporation HAE | EVP and General Counsel | 10,578 0.0206% | $87.71 | $927,796 | +6.12% | |
| 2020-06-12 | Sale | Haemonetics Corporation HAE | EVP and General Counsel | 203 0.0004% | $89.29 | $18,126 | +6.96% |